2-[1-[3-(4-bromo-2-fluorophenyl)-2-oxopropyl]-2,5-dioxo-4-propan-2-ylimidazolidin-4-yl]-N-(2-hydroxyethyl)acetamide

C19H23BrFN3O5 — CID 152884170

IUPAC2-[1-[3-(4-bromo-2-fluorophenyl)-2-oxopropyl]-2,5-dioxo-4-propan-2-ylimidazolidin-4-yl]-N-(2-hydroxyethyl)acetamide
SMILESCC(C)C1(CC(=O)NCCO)NC(=O)N(CC(=O)Cc2ccc(Br)cc2F)C1=O
InChIInChI=1S/C19H23BrFN3O5/c1-11(2)19(9-16(27)22-5-6-25)17(28)24(18(29)23-19)10-14(26)7-12-3-4-13(20)8-15(12)21/h3-4,8,11,25H,5-7,9-10H2,1-2H3,(H,22,27)(H,23,29)
InChIKeyUCBIUVUZKFTZOW-UHFFFAOYSA-N
MW472.31 g/mol
LogP1.14
Rot. Bonds9

About 2-[1-[3-(4-bromo-2-fluorophenyl)-2-oxopropyl]-2,5-dioxo-4-propan-2-ylimidazolidin-4-yl]-N-(2-hydroxyethyl)acetamide

2-[1-[3-(4-bromo-2-fluorophenyl)-2-oxopropyl]-2,5-dioxo-4-propan-2-ylimidazolidin-4-yl]-N-(2-hydroxyethyl)acetamide (PubChem CID 152884170) has the molecular formula C19H23BrFN3O5 and a molecular weight of 472.31 g/mol. Its IUPAC name is 2-[1-[3-(4-bromo-2-fluorophenyl)-2-oxopropyl]-2,5-dioxo-4-propan-2-ylimidazolidin-4-yl]-N-(2-hydroxyethyl)acetamide.

Molecular Properties

Compound Name2-[1-[3-(4-bromo-2-fluorophenyl)-2-oxopropyl]-2,5-dioxo-4-propan-2-ylimidazolidin-4-yl]-N-(2-hydroxyethyl)acetamide
PubChem CID152884170
Molecular FormulaC19H23BrFN3O5
Molecular Weight472.31 g/mol
Exact Mass471.08
IUPAC Name2-[1-[3-(4-bromo-2-fluorophenyl)-2-oxopropyl]-2,5-dioxo-4-propan-2-ylimidazolidin-4-yl]-N-(2-hydroxyethyl)acetamide
SMILESCC(C)C1(CC(=O)NCCO)NC(=O)N(CC(=O)Cc2ccc(Br)cc2F)C1=O
InChIInChI=1S/C19H23BrFN3O5/c1-11(2)19(9-16(27)22-5-6-25)17(28)24(18(29)23-19)10-14(26)7-12-3-4-13(20)8-15(12)21/h3-4,8,11,25H,5-7,9-10H2,1-2H3,(H,22,27)(H,23,29)
InChIKeyUCBIUVUZKFTZOW-UHFFFAOYSA-N
XLogP1.14
TPSA115.81 Ų
H-Bond Donors3
H-Bond Acceptors5
Rotatable Bonds9
Heavy Atoms29
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500472.31
LogP ≤ 51.14
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hydantoin', 'substructure': 'N/A'}

Analyze 2-[1-[3-(4-bromo-2-fluorophenyl)-2-oxopropyl]-2,5-dioxo-4-propan-2-ylimidazolidin-4-yl]-N-(2-hydroxyethyl)acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[1-[3-(4-bromo-2-fluorophenyl)-2-oxopropyl]-2,5-dioxo-4-propan-2-ylimidazolidin-4-yl]-N-(2-hydroxyethyl)acetamide?
The IUPAC name of 2-[1-[3-(4-bromo-2-fluorophenyl)-2-oxopropyl]-2,5-dioxo-4-propan-2-ylimidazolidin-4-yl]-N-(2-hydroxyethyl)acetamide (CID 152884170) is 2-[1-[3-(4-bromo-2-fluorophenyl)-2-oxopropyl]-2,5-dioxo-4-propan-2-ylimidazolidin-4-yl]-N-(2-hydroxyethyl)acetamide.
What is the SMILES notation for 2-[1-[3-(4-bromo-2-fluorophenyl)-2-oxopropyl]-2,5-dioxo-4-propan-2-ylimidazolidin-4-yl]-N-(2-hydroxyethyl)acetamide?
The canonical SMILES for 2-[1-[3-(4-bromo-2-fluorophenyl)-2-oxopropyl]-2,5-dioxo-4-propan-2-ylimidazolidin-4-yl]-N-(2-hydroxyethyl)acetamide is CC(C)C1(CC(=O)NCCO)NC(=O)N(CC(=O)Cc2ccc(Br)cc2F)C1=O.
What is the InChIKey of 2-[1-[3-(4-bromo-2-fluorophenyl)-2-oxopropyl]-2,5-dioxo-4-propan-2-ylimidazolidin-4-yl]-N-(2-hydroxyethyl)acetamide?
The InChIKey is UCBIUVUZKFTZOW-UHFFFAOYSA-N. The full InChI is InChI=1S/C19H23BrFN3O5/c1-11(2)19(9-16(27)22-5-6-25)17(28)24(18(29)23-19)10-14(26)7-12-3-4-13(20)8-15(12)21/h3-4,8,11,25H,5-7,9-10H2,1-2H3,(H,22,27)(H,23,29).
What are the key properties of 2-[1-[3-(4-bromo-2-fluorophenyl)-2-oxopropyl]-2,5-dioxo-4-propan-2-ylimidazolidin-4-yl]-N-(2-hydroxyethyl)acetamide?
2-[1-[3-(4-bromo-2-fluorophenyl)-2-oxopropyl]-2,5-dioxo-4-propan-2-ylimidazolidin-4-yl]-N-(2-hydroxyethyl)acetamide has a molecular weight of 472.31 g/mol, XLogP of 1.14, 9 rotatable bonds, 3 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[1-[3-(4-bromo-2-fluorophenyl)-2-oxopropyl]-2,5-dioxo-4-propan-2-ylimidazolidin-4-yl]-N-(2-hydroxyethyl)acetamide is sourced from PubChem (CID 152884170), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).